[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"health-study-detail:100600150":3},{"organization":4,"armGroups":7,"interventions":14,"overallOfficials":20,"centralContacts":21,"locations":30,"responsibleParty":51,"collaborators":53,"id":55,"slug":56,"hasResults":57,"nctId":58,"briefTitle":59,"officialTitle":60,"acronym":61,"eligibilityCriteria":62,"healthyVolunteers":57,"sex":63,"minAge":64,"maxAge":65,"enrollmentInfo":66,"targetDuration":20,"studyType":69,"phases":70,"briefSummary":72,"conditions":73,"keywords":81,"overallStatus":33,"whyStopped":20,"lastUpdateSubmitDate":86,"lastUpdatePostDateStruct":87,"startDateStruct":90,"completionDateStruct":92,"leadSponsor":94,"locationsCount":95},{"fullName":5,"class":6},"Murdoch Childrens Research Institute","OTHER",[8],{"label":9,"type":10,"description":11,"interventionNames":12},"Intervention arm","EXPERIMENTAL","All participants eligible participants parent\u002Fguardian will be asked to complete:\n\n1. Daily symptom tracking questionnaires for the duration of their antibiotic course\n2. One-time questionnaire (at enrolment) about parents\u002Fguardians' perspectives on antibiotic course duration and stopping antibiotics early\n3. Two short follow up questionnaires (day 14 and day 28) to record if antibiotics have been restarted and for perspectives\u002Fconcerns and feedback on study instruments and procedures.\n\nIn addition, a small number of participants will also be asked to wear a Garmin Smartwatch for the duration of their antibiotic course (3 devices only available, will be offered when available - approximately 60 participants).",[13],"Device: Garmin Smartwatch",[15],{"type":16,"name":17,"description":18,"armGroupLabels":19,"otherNames":20},"DEVICE","Garmin Smartwatch","Garmin Venu 3 - Worn for the duration of antibiotic course",[9],null,[22,27],{"name":23,"role":24,"phone":25,"phoneExt":20,"email":26},"A\u002FProf Penelope Bryant","CONTACT","+61383416200","penelope.bryant@rch.org.au",{"name":28,"role":24,"phone":25,"phoneExt":20,"email":29},"Lucy Hill","lucy.hill@mcri.edu.au",[31],{"facility":32,"status":33,"city":34,"state":35,"zip":36,"country":37,"countryCode":38,"cosmosGeoPoint":39,"geoPoint":44,"contacts":45},"Royal Children's Hospital","RECRUITING","Melbourne","Victoria","3052","Australia","AU",{"type":40,"coordinates":41},"Point",[42,43],144.96332,-37.814,{"lat":43,"lon":42},[46,48,49],{"name":23,"role":24,"phone":47,"phoneExt":20,"email":26},"+61393455522",{"name":28,"role":24,"phone":20,"phoneExt":20,"email":29},{"name":23,"role":50,"phone":20,"phoneExt":20,"email":20},"PRINCIPAL_INVESTIGATOR",{"type":52,"investigatorFullName":20,"investigatorTitle":20,"investigatorAffiliation":20,"oldNameTitle":20,"oldOrganization":20},"SPONSOR",[54],{"name":32,"class":6},"100600150","perspectives-on-antibiotics-and-tracking-symptoms-in-children-100600150",false,"NCT07093749","Perspectives on Antibiotics and Tracking Symptoms in Children","PATSy Perspectives on Antibiotics and Tracking Symptoms in Children - a Mixed Methods Feasibility Study","PATSy","Inclusion Criteria:\n\n* Between the ages of ≥ 4 years and ≤ 17 years at enrolment.\n* Diagnosed with any of the following at RCH ED: urinary tract infection (UTI), cellulitis, impetigo, pharyngitis, tonsillitis, respiratory tract infections, otitis media.\n* Prescribed oral antibiotics (either immediately or as switch from IV antibiotics after transfer to HITH) as standard of care due to having uncomplicated infection as deemed by their treating doctor.\n* Parent\u002Fguardian provides a signed and dated informed consent form.\n\nExclusion Criteria:\n\n\\- Parent\u002Fguardian does not speak English","ALL","4 Years","17 Years",{"count":67,"type":68},300,"ESTIMATED","INTERVENTIONAL",[71],"NA","The study will assess families' perspectives and decision-making regarding the duration of oral antibiotic courses prescribed to children (4-17 years) who present with uncomplicated bacterial infections at the Royal Children's Hospital (RCH) Emergency Department (ED). The study will involve (i) children discharged from ED on oral antibiotics and (ii) children transferred to Hospital-in-the-Home (HITH) on IV antibiotics who then switch to oral antibiotics. In addition, the study will assess how feasible and acceptable it is to track children's symptoms via the Garmin Smartwatch and the WeGuide platform (WeGuide is a patient engagement software platform that allows for enrolment, consent, and data collection \\[via questionnaires\u002Fsurveys and from the Garmin Smartwatches\\] through a singular platform).",[74,75,76,77,78,79,80],"Urinary Tract Infection","Cellulitis","Impetigo","Pharyngitis","Tonsillitis","Respiratory Tract Infections","Otitis Media",[82,83,84,85],"Paediatrics","Antibiotics","Digital Health","Infection","2025-09-17",{"date":88,"type":89},"2025-09-22","ACTUAL",{"date":91,"type":89},"2025-09-16",{"date":93,"type":68},"2026-08",{"name":5,"class":6},1]